{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Oncology Times: December 2011

Activity Steps

1 Activity
2 Take Test 3Certificate

Purpose of Activity

To present registered professional nurses with the latest information about diagnostic and treatment options for chronic myeloid leukemia (CML) and multiple myeloma (MM).

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Discuss current trial results and treatment options for patients with CML.
  2. Outline the indications for and benefits of allogeneic stem cell transplantation for patients with high-risk MM.

Disclosures

The author and planners have disclosed that they have no financial relationships related to this article.

Price: $21.95

Credits:

  • ANCC 2.4 CH
  • DC - BON 2.4 CH
  • KY-BON 2.4 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
--------------------------------------------------
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
--------------------------------------------------
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.





Planner
Test Code: OT1211
Published: December 10, 2011
Expires: 12/31/2026
Sources: Oncology Times
Required Passing Score: 11/15 (73%)
Authors: Mark Fuerst
Categories: Cancer , Drug Therapy , Hematology , Oncology
Specialties: Oncology
Topics: Leukemia , Multiple Myeloma